Response and resistance in immuno-oncology
Published January 25, 2021 Find resources and tools for understanding tumor-specific response and resistance to cancer immunotherapies. Overview What is immunotherapy? The role of the immune system Flexible, validated research solutions Key targets involved in tumor resistance: STING, IDO1, and VISTA STING IDO1 VISTA New flow cytometry antibodies to support the studies of live cells Antibody panels to increase your chance of success Advancing immuno-oncology research, together What is immunotherapy? Immunotherapy is a revolutionary approach to cancer treatment that helps…